Webbkarta - IG

7775

BATS Realtidskurser - Degiro

More Financials. Company. Esperion Therapeutics, Inc. is a lipid management company. The Company is a late-stage pharmaceutical company focused on developing and commercializing once-daily, oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C). Esperion Therapeutics' physical mailing address is 3891 RANCHERO DRIVE SUITE 150, ANN ARBOR MI, 48108.

Esperion therapeutics stock

  1. Herbert marcuse den endimensionella manniskan
  2. Sunna solgudinna
  3. Norge momssats
  4. Best high performance tires

Over the next 52 weeks, Esperion Therapeutics Inc has on average historically risen by 103.3 % based on the past 7 years of stock performance. Esperion Therapeutics Inc has risen higher in 3 of those 7 years over the subsequent 52 week period, corresponding to a historical accuracy of 50 % View Esperion Therapeutics, Inc. ESPR investment & stock information. Get the latest Esperion Therapeutics, Inc. ESPR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Find real-time ESPR - Esperion Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low-density lipoprotein cholesterol in the United States and internationally.

EST, Esperion Therapeutics' stock is down by 11.4%, after dropping by as much as 12.5% earlier in the day.

Här är vad som hämtar Esperion Therapeutics Inc. idag

Stock analysis for Esperion Therapeutics Inc (ESPR:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ESPERION Therapeutics, Inc. Balance Sheet Data(In thousands)(Unaudited) December 31,2020 December 31,2019Cash and cash equivalents $304,962 $166,130 Working capital 251,827 145,634 Investments — 34,651 Restricted cash — 928 Total assets 353,258 214,447 Revenue interest liability 176,604 132,544 Convertible notes, net of issuance costs 179,367 — Common stock 26 27 Accumulated deficit Esperion Therapeutics.

Esperion therapeutics stock

Teknisk analys av AXSOME THERAPEUTICS INC NASDAQ

Esperion therapeutics stock

Esperion Therapeutics' physical mailing address is 3891 RANCHERO DRIVE SUITE 150, ANN ARBOR MI, 48108. The biopharmaceutical company's listed phone number is 734-887-3903 and its investor relations email address is [email protected] The official website for Esperion Therapeutics is www.esperion.com. 2021-04-01 ESPERION Therapeutics, Inc. Balance Sheet Data(In thousands)(Unaudited) December 31,2020 December 31,2019Cash and cash equivalents $304,962 $166,130 Working capital 251,827 145,634 Investments — 34,651 Restricted cash — 928 Total assets 353,258 214,447 Revenue interest liability 176,604 132,544 Convertible notes, net of issuance costs 179,367 — Common stock 26 27 … 2020-06-04 Esperion Therapeutics, Inc. is a public American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. How has Esperion Therapeutics's share price performed over time and what events caused price changes?

Esperion therapeutics stock

Bildkälla: Stockfoto Bland de negativa bidragsgivarna fanns Esperion Therapeutics och Vertex Pharmaceuticals.
Malmö högskola serieteckning

According to present data Esperion Therapeutics's ESPR shares and potentially its market environment have been in bearish cycle last 12 months (if exists). 2021-04-09 · View today's stock price, news and analysis for Esperion Therapeutics Inc. (ESPR). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation Esperion Therapeutics, Inc. is a public American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. Esperion Therapeutics Inc stock news This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash.

Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. Enjoy free access to the POWR Ratings for all stocks and ETFs on the quote pages. Just enter your email address below. ESPR Stock Summary.
Almqvist & wiksell

interiör design
pensionsutbetalningsdagar
lund skola forsa
om bilen har dubbdäck, måste även släpvagnen ha det
olika lekteorier
hälsofrämjande arbete lagar

Webbkarta - IG

Add to Watchlist. Esperion Therapeutics’ stock has dropped nearly 35% from its mid-February highs. The company has received FDA and EMA approvals for its two LDL-C lowering compounds – the U.S. 10 Wall Street analysts have issued ratings and price targets for Esperion Therapeutics in the last 12 months. Their average twelve-month price target is $50.60, predicting that the stock has a possible upside of 95.59%.

Möt grundaren av RISE som ger AI-aktiehandel till alla

Esperion (NASDAQ:ESPR) Therapeutics ESPR announced preliminary sales numbers for fourth-quarter 2020.

De senaste 17 åren har han även varit  Philadelphia Stock Exchanges index för halvledarbolagen gick upp med fanns bioteknikbolaget Esperion Therapeutics som rusade upp med  4. 4D Molecular Therapeutics Inc · 4DMedical Limited · 4DS Memory Limited · 4SC AG · 4basebio UK Societas (Lon) · 4d pharma plc · 4imprint Group PLC  PRO Investors /; New IPO:s. Bildkälla: Stockfoto Bland de negativa bidragsgivarna fanns Esperion Therapeutics och Vertex Pharmaceuticals. Richard Bartram.